"Thrombocythemia" Natural Recordings by Native Speakers
Thrombocythemia is a medical condition characterized by an increased number of platelets in the blood, also known as thrombocytosis. It is a myeloproliferative neoplasm, a group of disorders in which the bone marrow produces too many cells. In thrombocythemia, the bone marrow produces too many platelets, which can lead to an increased risk of blood clots and other bleeding complications.
There are two main types of thrombocythemia:
1. Essential thrombocythemia (ET): a benign condition in which the bone marrow produces too many platelets, but it is not caused by another underlying disease.
2. Chronic myeloid leukemia (CML): a myeloproliferative neoplasm in which the bone marrow produces too many platelets, white blood cells, and red blood cells.
Symptoms of thrombocythemia may include:
Bruising or bleeding easily
Dizziness or lightheadedness
Shortness of breath
Headaches
Weakness
Pain in the abdomen or bones
Petechiae (small red spots on the skin)
Treatment for thrombocythemia usually involves controlling the platelet count with medications, and in some cases, surgery or radiation therapy may be necessary to remove abnormal bone marrow.
Thrombinase is a term that may refer to several enzymes involved in the coagulation cascade, specifically those that activate thrombin.<br><br>In that context, thrombinase can refer to:<br><br>1. Thrombin-like enzymes: These enzymes, such as Factor Xa or Factor IXa, can activate prothrombin to produce thrombin, but they are not identical to thrombin itself.<br>2. Thrombin activators: These are enzymes that can activate thrombin to create a more potent form of thrombin, such as Factor XIa or Factor XIIa.<br>3. Thrombin generation assays: In clinical laboratory settings, thrombin generation assays may refer to the measurement of thrombin generation through the activation of platelets and coagulation factors.<br><br>However, it's worth noting that "thrombinase" is not a commonly used term in the bleeding disorders community, and most people refer to the thrombin-activating cascade as the coagulation cascade or the extrinsic pathway.<br><br>A more accurate term may be "thrombin generating enzyme" or "pro-thrombin activator", relying on the specific enzyme being referenced.
Thromboangiitis refers to the inflammation of blood vessels due to an abnormality of the blood or an unusual narrowing of the vessels.
Pertaining to thrombosis (the formation of blood clots) or the breakdown or destruction of cells called thrombocytes (platelets).
A thrombocyte, also known as a platelet, is a small blood cell that plays a crucial role in the process of blood clotting. It is a type of cytoplasmic fragment or spherocyte found in the blood. Thrombocytes are produced in the megakaryocytes, a type of bone marrow cell, and are released into the circulation to help stop bleeding when a vessel is injured. They are attracted to the site of an injury, where they aggregate and form a platelet plug to facilitate clotting. Thrombocytes have no nucleus and are rich in various proteins that are essential for initiating blood coagulation, including adhesion, aggregation, and thrombin production. The normal range for this cell type in a healthy individual is approximately 150,000 to 450,000 thrombocytes per microliter of blood.